A E Kalaydjian1, W Eaton, N Cascella, A Fasano. 1. Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. akalaydj@jhsph.edu
Abstract
OBJECTIVE: Schizophrenia affects roughly 1% of the population and is considered one of the top 10 causes of disability worldwide. Given the immense cost to society, successful treatment options are imperative. Based on initial findings, gluten withdrawal may serve as a safe and economical alternative for the reduction of symptoms in a subset of patients. METHOD: A review of the literature relevant to the association between schizophrenia and celiac disease (gluten intolerance) was conducted. RESULTS: A drastic reduction, if not full remission, of schizophrenic symptoms after initiation of gluten withdrawal has been noted in a variety of studies. However, this occurs only in a subset of schizophrenic patients. CONCLUSION: Large-scale epidemiological studies and clinical trials are needed to confirm the association between gluten and schizophrenia, and address the underlying mechanisms by which this association occurs.
OBJECTIVE:Schizophrenia affects roughly 1% of the population and is considered one of the top 10 causes of disability worldwide. Given the immense cost to society, successful treatment options are imperative. Based on initial findings, gluten withdrawal may serve as a safe and economical alternative for the reduction of symptoms in a subset of patients. METHOD: A review of the literature relevant to the association between schizophrenia and celiac disease (gluten intolerance) was conducted. RESULTS: A drastic reduction, if not full remission, of schizophrenic symptoms after initiation of gluten withdrawal has been noted in a variety of studies. However, this occurs only in a subset of schizophrenicpatients. CONCLUSION: Large-scale epidemiological studies and clinical trials are needed to confirm the association between gluten and schizophrenia, and address the underlying mechanisms by which this association occurs.
Authors: Jessica Jackson; William Eaton; Nicola Cascella; Alessio Fasano; Dale Warfel; Stephanie Feldman; Charles Richardson; Gopal Vyas; Jared Linthicum; Debby Santora; Kimberly R Warren; William T Carpenter; Deanna L Kelly Journal: Schizophr Res Date: 2012-07-07 Impact factor: 4.939
Authors: William W Eaton; Lian-Yu Chen; F Curtis Dohan; Deanna L Kelly; Nicola Cascella Journal: Am J Psychiatry Date: 2015-03-01 Impact factor: 18.112
Authors: Olaoluwa Okusaga; Dietmar Fuchs; Gloria Reeves; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Maureen Groer; Thomas B Cook; Kelly A Stearns-Yoder; Janardan P Pandey; Deanna L Kelly; Andrew J Hoisington; Christopher A Lowry; William W Eaton; Lisa A Brenner; Dan Rujescu; Teodor T Postolache Journal: Psychosom Med Date: 2016-10 Impact factor: 4.312
Authors: Emily G Severance; Armin Alaedini; Shuojia Yang; Meredith Halling; Kristin L Gressitt; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; F Markus Leweke; Faith B Dickerson; Robert H Yolken Journal: Schizophr Res Date: 2012-03-24 Impact factor: 4.939
Authors: Nicola G Cascella; Debra Kryszak; Bushra Bhatti; Patricia Gregory; Deanna L Kelly; Joseph P Mc Evoy; Alessio Fasano; William W Eaton Journal: Schizophr Bull Date: 2009-06-03 Impact factor: 9.306